Literature DB >> 7847816

Evidence for the involvement of sulfhydryl groups in the expression of antitumor activity of streptococcal acid glycoprotein (SAGP) purified from crude extract of Streptococcus pyogenes.

J Yoshida1, S Takamura, S Suzuki.   

Abstract

An acidic glycoprotein (SAGP), purified from crude extract (CE) of Streptococcus pyogenes, inhibits the growth of murine fibrosarcoma (Meth A) cells in vitro and prolongs the life span of mice inoculated with the same cells. This study revealed that the growth inhibitory activity of SAGP on Meth A cells in vitro was lowered in the presence of sulfhydryl-oxidizing agents such as cystamine and 5, 5'-dithiobis (2-nitrobenzoic acid) in a dose dependent manner. The activity of SAGP was also diminished by pretreatment of SAGP with cystamine. Inactivation of SAGP by cystamine was reversed by dithiothreitol. Furthermore, the effect of CE on prolonging the life span of Meth A-bearing mice was reduced by the administration of cystamine. These findings suggest that SH-groups are involved in the expression of anti-tumor activity of SAGP or CE in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7847816

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein.

Authors:  B A Degnan; M C Fontaine; A H Doebereiner; J J Lee; P Mastroeni; G Dougan; J A Goodacre; M A Kehoe
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity.

Authors:  B A Degnan; J M Palmer; T Robson; C E Jones; M Fischer; M Glanville; G D Mellor; A G Diamond; M A Kehoe; J A Goodacre
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 3.  Streptococcal bacterial components in cancer therapy.

Authors:  Zeynab Marzhoseyni; Layla Shojaie; Seyed Alireza Tabatabaei; Ahmad Movahedpour; Mahmood Safari; Davoud Esmaeili; Maryam Mahjoubin-Tehran; Amin Jalili; Korosh Morshedi; Haroon Khan; Ranaa Okhravi; Michael R Hamblin; Hamed Mirzaei
Journal:  Cancer Gene Ther       Date:  2021-03-22       Impact factor: 5.987

4.  Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein.

Authors:  J Yoshida; S Takamura; S Suzuki; M Nishio
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.